pmid,title,journal,year,drug,disease
35779197,Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.,PharmacoEconomics,2022,Molnupiravir,Prostate Cancer
